A Trial of Selinexor, Ruxolitinib and Methylprednisolone

Clinical trial NCT06225310 · RECRUITING

Trial details

NCT number: NCT06225310
Sponsor: Oncotherapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Multiple Myeloma, Refractory

Start date: 2024-08-06
Primary completion: 2027-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.